Delivery Order SPE2DB22D1103-SPE2DB24FTQH3

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,360.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a $3,156 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $3,156.00 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range...
The Defense Logistics Agency (DLA) awarded a $3,208.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract has a completion date of May 14, 2024 and was awarded on May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,052.00 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $2,434.19 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract worth $2,630.00 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,839.97, is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,680 firm-fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has numerous Indefinite Delivery Contracts (IDCs) with federal agencies,...
The U.S. Defense Logistics Agency (DLA) awarded a $5,523 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565440991 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTQH3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,367.00 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. This contract has an ultimate completion date of August 20, 2024. AmerisourceBergen, a for-profit organization, holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award is not designated as a set-aside.

Generated 11/18/24, 9:25 AM